SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-057543
Filing Date
2015-06-30
Accepted
2015-06-30 16:12:08
Documents
2
Period of Report
2015-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2172
2 POA DOCUMENT poa.txt EX-24.3_592496 4237
  Complete submission text file 0001209191-15-057543.txt   7902
Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139
Business Address
Arbuckle Stuart A (Reporting) CIK: 0001557290 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36395 | Film No.: 15961551